clinical trial · NCT07789028
A Study in Healthy People to Test How Zongertinib is Taken up in the Body When Given as Tablets Made by Two Different Manufacturers With or Without Food
HealthyZongertinib, Formulation A, reference productZongertinib Formulation B, test product
brief summary
The main objective of this trial is to establish the bioequivalence of Zongertinib tablets from two different manufacturers following oral administration.
started
Sep 9, 2026
primary completion
Dec 15, 2026
completion
Dec 21, 2026
last updated
Aug 27, 2026
official title
Bioequivalence of Zongertinib Tablets From Two Different Manufacturers Following Oral Administration in Healthy Male and Female Trial Participants in Fasted and Fed State (an Open-label, Randomised, Single-dose, Four-period, Four-sequence Crossover Trial)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol